Roche: extends offer period in Spark takeover
(CercleFinance.com) - Swiss drugmaker Roche said that shareholders in US takeover target Spark Therapeutics may tender their shares for an additional month, beginning tomorrow.
The takeover offer - which was first set to expire on 3 September - has been extended until 1 October, the company said.
Roche said the offer has been extended to provide additional time for the US Federal Trade Commission (FTC) and the UK Competition and Markets Authority (CMA) to complete their reviews of the deal.
Roche also said it now owns approximately 24.1% of Spark's shares in issue.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The takeover offer - which was first set to expire on 3 September - has been extended until 1 October, the company said.
Roche said the offer has been extended to provide additional time for the US Federal Trade Commission (FTC) and the UK Competition and Markets Authority (CMA) to complete their reviews of the deal.
Roche also said it now owns approximately 24.1% of Spark's shares in issue.
Copyright (c) 2019 CercleFinance.com. All rights reserved.